Last Updated: September 12, 2026
340B recertification documentation for STD clinics tightened in two stages: HRSA's August 2025 information-collection notice and the January 2026 follow-up (hrsa.gov). Together they raised the evidentiary bar for Section 318 entities whose eligibility rests on in-kind support rather than direct grant funding. This guide from The Marketing Lab covers what changed, what to hold, and how to get ahead of the February recertification window.
The practical shift is narrow but consequential. HRSA now expects a complete paper trail connecting the in-kind support to 318 dollars, not just a letter confirming the support exists. A single-date entry on a form no longer satisfies the standard. In programs we run, we have seen clinics need to reconstruct documentation after discovering their files showed one date where HRSA wanted a range.
Below, the checklist table, the four elements of an executed subrecipient agreement, and the pitfalls that sink otherwise compliant clinics.
The core requirement is simple to state: prove the in-kind support was purchased with 318 funds and flowed from an eligible grantee to your clinic. The proof is harder to assemble than most program managers expect, particularly when the state health department is the source of the support.
Every Section 318 entity relying on in-kind support should maintain the following in a single, audit-ready file. The right-hand column is what actually gets checked, not what the document is titled.
| Document | Who Provides It | What HRSA Actually Checks | Common Gap |
|---|---|---|---|
| Notice of Award | State health department grantee | Current award year, grantee legal name and address | Expired award year on file |
| Executed subrecipient agreement | Grantee and clinic | Both signatures, all four required elements | Unsigned draft |
| 318 purchase proof | Grantee | Invoice or PO showing 318 as the funding source | Invoice without funding source |
| In-kind date range | Grantee | Start and end date, not a single date | Single date entered |
| 340B ID and OPAIS record | Clinic | Entity name and address match the file | Stale address after a move |
| Prescriber roster | Clinic and TPA | Rendering NPIs, including supervised mid-levels | Missing mid-level NPIs |
| Medicaid Exclusion File | Clinic | Entity Medicaid ID listed correctly | Carve-in status not updated |
The agreement must show four things, and HRSA's notices are specific about each:
Where a form asks for a "MOU agreement number," there is no HRSA-issued MOU number. It is a state contract number, the CDC cooperative agreement number, or a wholesaler or TPA account number. Ask which before answering.
Run this pass in the fall, not in February. It takes a program manager a few hours per site and surfaces almost every gap HRSA would flag.
RxLeverage builds and maintains these files as part of full-service 340B third-party administration, including eligibility documentation, subrecipient agreement tracking, and HRSA audit readiness.
340B in-kind support documentation must demonstrate that the donated item, most often HIV test kits, was purchased with Section 318 dollars. A letter confirming the donation is not enough. The file needs the purchase record showing the funding source.
In our experience, the state health department holds the purchase records, not the clinic. That means the clinic has to request them, and state document requests move slowly. Programs that wait until January to request 318 purchase documentation routinely miss the February window.
The HRSA 340B recertification timeline is unforgiving because the critical documents sit with a third party. Recertification opens in the February window, but the documents that support it come from the state health department, which operates on its own schedule.
The practical problem is that the state health department is not on your timeline, and a single stalled records request can push the whole file past the deadline. Work backward from February and treat each step as a dependency, not a task.
| Window | Action | Why It Blocks the Next Step |
|---|---|---|
| September-October | Request the current Notice of Award and the executed subrecipient agreement from the grantee | You cannot verify the four required elements without the signed agreement in hand |
| October-November | Request 318 purchase documentation for all in-kind items | Purchase records come from the grantee or state, not the clinic, and take weeks |
| November-December | Reconcile the prescriber roster against an EHR claims report by rendering NPI | Roster fixes require TPA config changes, which have their own turnaround |
| December-January | Confirm the Medicaid Exclusion File shows the entity's Medicaid ID | Carve-in status errors surface here, not in February |
| January | Assemble the complete file and run a final self-audit | Leaves a buffer for anything the DOH has not yet returned |
| February | Submit recertification with the complete file | No open items, no unsigned drafts, no single-date entries |
State document requests move slowly, and a request that sits for six weeks in November is a February problem. Build in a follow-up cadence and an escalation path.
A documentation gap that exists this year usually existed last year too. If the in-kind file is incomplete at recertification, the exposure is not limited to the current cycle, the repayment period extends to match the years the gap covers. That is why the fall review cycle is a year-round discipline, not a February task.
RxLeverage runs this sequence for covered entities as part of full-service 340B third-party administration, including eligibility documentation, subrecipient agreement tracking, and HRSA audit readiness.
Internal audit preparation is where disciplined programs separate from reactive ones. The two files that drift most are the prescriber roster and the in-kind documentation, and both fail silently until an audit surfaces the gap.
Run a quarterly reconciliation:
In one audit we reviewed, roughly a third of active rendering providers were missing from the TPA configuration, including the owner, because mid-levels rendered under a supervising NPI. The roster looked complete until it was checked against claims.
The pitfalls in 340B recertification cluster around documentation that looks complete but is not. These are the ones that recur across the programs we administer.
Each of these is avoidable with a fall review cycle. None is avoidable in February.
Failed recertification ends participation. HRSA removes the entity from the 340B Program, and removal triggers manufacturer repayment for discounts taken while ineligible (hrsa.gov). For a Section 318 clinic, that means the pharmacy savings that fund its prevention work stop, and the repayment obligation arrives at the same time.
The exposure is not limited to the recertification year. If the documentation gap existed for multiple years, the repayment period extends to match. This is why the in-kind file matters beyond the current cycle: it is the record that defends every prior year.
Recertification documentation is a records problem, not a clinical one, and it rewards clinics that treat it as a year-round discipline rather than a February task. The Marketing Lab runs RxLeverage for covered entities that need eligibility and recertification files built and defended, with performance-aligned pricing and zero base fees. Book a free 30-minute strategy call at https://thelab.marketing/schedule and get the file ready before the window opens.
Section 318 STD clinics need the grantee's current Notice of Award, an executed subrecipient agreement with recipient and subrecipient names and addresses, the grant number, the NOFO number, and terms of support, plus proof that any in-kind support was purchased with 318 funds. HRSA also expects the 340B ID, authorizing official contact details, and site registration records. Single-date in-kind entries and unsigned drafts are the most common gaps we see in files.
Proof requires three linked documents: the grantee's Notice of Award, an executed subrecipient agreement showing the four required elements, and purchase records demonstrating the in-kind support was bought with 318 dollars. The in-kind contribution must show a funding date range, not a single date. HRSA tightened this expectation in its August 2025 and January 2026 information-collection notices, so files built under older assumptions often fail review.
HRSA can remove the entity from the 340B Program, which ends access to ceiling-price drugs and contract pharmacy arrangements. Removal also triggers manufacturer repayment obligations for drugs purchased at 340B pricing while the entity was ineligible. In our experience, the repayment exposure grows with the length of the ineligible period, so clinics should treat any documentation gap as urgent rather than waiting for the next recert window.
HRSA's annual recertification window typically runs from mid-February through early March, with the exact dates published each year in the 340B OPAIS portal. STD clinics relying on in-kind support should start requesting documents from their state health department months before the window opens. In our experience, DOH document requests routinely take four to eight weeks, so February is too late to begin.
The August 2025 and January 2026 notices tightened what HRSA accepts as proof of in-kind support for Section 318 entities. Single-date entries, unsigned subrecipient drafts, and purchase records without a clear 318 funding trail no longer pass review. Clinics should audit their files now, confirm the subrecipient agreement shows recipient and subrecipient names and addresses, grant number, NOFO number, and terms of support, and rebuild any file that falls short.
Bring us your patient acquisition, 340B program, or compliance bottleneck. We will show you what a 30-day launch looks like for your clinic — in English or Spanish, month to month, no long contract.
